• Facebook Social Icon
  • Twitter Social Icon
  • Instagram Social Icon

Psoriasis Trial 2

Study Name: PSORIASIS TRIAL 2

Clinics: Cannock, Manchester and Teesside

Therapy Area: Plaque Psoriasis

Gender and Age: Male and female aged 18 and over

Description: 

MAC is currently conducting a trial to test a new oral treatment for moderate to severe plaque psoriasis. Plaque psoriasis is a chronic inflammatory skin disorder and is the most common form of the condition, affecting up to 3% of the general population. It is characterised primarily by red scaly plaques that normally appear on elbows, knees, scalp and lower back, but can appear anywhere on the body.

The purpose of this trial is to measure how safe and effective the trial medication is in treating participants with psoriasis.

 

Reimbursement:

Reasonable travel expenses or transport to the clinic will be provided.

Criteria:

Key Inclusion Criteria:

  • Men and women aged ≥18 years

  • Diagnosis of stable plaque psoriasis ≥6 months

Key Exclusion Criteria:

  • Has non-plaque psoriasis

  • History of serious bacterial, fungal, or viral infections requiring hospitalization within the past 3 months or any infection requiring antibiotic treatment within the past 15 days

 

Other eligibility criteria will apply. Please contact MAC for more information.

Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.